ask="N/A"
ask_size="N/A"
average_daily_volume="187745"
bid="0.01"
bid_size="100"
book_value="0.56"
change="-0.02"
change_from_200_day_moving_average="0.27"
change_from_50_day_moving_average="0.18"
change_from_52_week_high="-1.17"
change_From_52_week_low="0.73"
change_in_percent="-0.74%"
close="2.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.34"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="2.77"
high_52_weeks="3.87"
last_trade_date="1/23/2017"
last_trade_price="2.70"
last_trade_size="100"
last_trade_time="3:58pm"
low="2.65"
low_52_weeks="1.97"
market_capitalization="50.45M"
moving_average_200_day="2.43"
moving_average_50_day="2.52"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="2.74"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+11.29%"
percent_change_from_50_day_moving_average="+7.05%"
percent_change_from_52_week_high="-30.23%"
percent_change_from_52_week_low="+37.06%"
previous_close="2.72"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.83"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="1.38"
stock_exchange="NCM"
symbol="BCLI"
volume="56371"
weeks_range_52="1.97 - 3.87"
